UNSPSC 41151720: Drug metabolizing enzyme genotyping system

In this classification, a Drug metabolizing enzyme genotyping system is a device intended to measure Drug metabolizing enzyme genotypesfor clinical toxicology purposes. US FDA regulates Drug metabolizing enzyme genotyping system under 21 CFR 862.3360 and under FDA product code NTI

UNSPSC 41151720 Drug metabolizing enzyme genotyping system is a Commodity code with no recent state and local procurement activity aligned to its scope. The recent opportunities block contains solicitations for timeclock equipment, hydrogen generator supplies, fire alarm components, spectrometer instruments, water testing reagents, X-ray equipment, laboratory analyzers, educational materials, and analytical systems—none of which match the pharmacogenomic testing or drug metabolism analysis that the code describes. The mismatch between the code's nominal scope and what state and local buyers are actually procuring under it suggests that either the code is seldom used for state and local contracts, or that issuers are misapplying it to unrelated equipment and supplies. Without decision-relevant recent opportunities in pharmacogenomics or clinical drug metabolism testing, the code shows minimal activity worth tracking for business development purposes at this time.